In our latest Trade to Black podcast, presented by Flowhub, hosts Shadd Dales and Anthony Varrell kick off a brand new week starting in the psychedelic space, where FDA officials laid out a new framework to make psychedelic therapies available to patients "more quickly," according to reporting from Marijuana Moment. In a piece published in the New England Journal of Medicine, four FDA staffers pointed to the country's worsening mental health crisis and named psilocybin and DMT specifically as compounds worth pursuing, building on steps FDA and HHS announced back in April to accelerate access. In segment two, Anthony Coniglio, CEO of NewLake Capital Partners (OTCQX: NLCP), joins to break down where cannabis rescheduling actually stands. It's now been roughly a month since post-hearing briefs were due, and they get into the timeline question everyone's asking, whether Judge Derek Julius issues his recommendation this week or if the wait continues.They also get into the interest rate environment and what it means for cannabis capital access. Anthony shares his outlook on how many more rate moves to expect, and walks through why rescheduling and monetary policy are two separate conversations, even if cannabis gets moved to Schedule III, that alone doesn't mean borrowing costs come down while rates remain elevated.Like, subscribe and leave your comments!Want to stay updated on Cannabis, Small Cap, AI, and Crypto?Subscribe to our Daily Baked newsletter:https://newsletter.thedalesreport.com...Find us on social media and podcast platforms:✅ Facebook:   / thedalesreport  ✅ Twitter:   / thedalesreport  ✅ Instagram:   / dalesreport  ✅ LinkedIn:   / the-dales-report  Apple Podcasts: https://tinyurl.com/TDRTradetoBlackon...Spotify: https://tinyurl.com/TDRTradeToBlackon...Website: https://thedalesreport.com/For copyright matters, contact:[email protected] Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions made based on the information discussed.Full Disclosures: https://thedalesreport.com/website-te...

In this episode of TDR Cannabis in 5, host Shadd Dales breaks down reporting from Bridge Michigan, republished by Marijuana Moment, on Republican candidate John James pledging to repeal or sharply reduce the state's new 24% wholesale marijuana tax, and the cannabis industry now putting real financial support behind him.James recently attended a fundraiser hosted by JARS Cannabis executives that raised nearly $90,000 for his campaign, part of the roughly $1.2 million he's raised since late July. The wholesale tax was created last year as part of a bipartisan road-funding deal signed by Governor Gretchen Whitmer, and it's separate from Michigan's existing 10% retail excise tax. Industry officials say they were blindsided by it, and the early numbers back up some of their frustration, the tax was projected to generate $420 million annually, but actual collections came in at just $73.4 million over the first six months.Democratic nominee Jocelyn Benson has taken a far more cautious stance, calling it a "new and emerging issue" that needs more data before she commits to a position. The episode also covers James's political evolution on cannabis, from opposing legalization back in 2018 to now positioning himself as a defender of the legal market voters created, and why this race could become a genuinely important test case as Michigan's saturated, thin-margin cannabis market decides whether legal prices stay competitive with the illicit market or push consumers right back to it.#TDRCannabisIn5 #Michigan #CannabisPolicy #JohnJames #CannabisTax #Gubernatorial2026 #CannabisNews #CannabisIndustry #WeedTax #MichiganCannabisWant to see more Cannabis Reform?🎬    • Legal Weed Could Bring in $58 Billion More...  🎬    • Regulate Hemp, Don't Destroy It, Says CEO ...  🎬    • Tyson Pushes Trump on Cannabis Reform | TD...  🎬    • Court Rejects Bid to Block Rescheduling | ...  Want to stay updated on Cannabis, Small Cap, AI, and Crypto?Subscribe to our Daily Baked newsletter:https://newsletter.thedalesreport.com...Find us on social media and podcast platforms:✅ Facebook:   / thedalesreport  ✅ Twitter:   / thedalesreport  ✅ Instagram:   / dalesreport  ✅ LinkedIn:   / the-dales-report  Apple Podcasts: https://tinyurl.com/TDRTradetoBlackon...Spotify: https://tinyurl.com/TDRTradeToBlackon...Website: https://thedalesreport.com/For copyright matters, contact:[email protected] Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions made based on the information discussed.Full Disclosures: https://thedalesreport.com/website-te...

In our latest Trade to Black Weekly Recap, presented by FRE, host Shadd Dales highlights the biggest developments in cannabis and psychedelics over the past 7 days, including a federal court ruling on rescheduling, Virginia's first draft of adult-use regulations, an escalating Curaleaf-Aurora fight, and a Compass Pathways update.First, the U.S. Court of Appeals for the D.C. Circuit rejected an attempt by NDASA and MMJ International Holdings to block Trump's cannabis rescheduling move while litigation continues, with DOJ arguing the challengers themselves have "pocketbook interests" in keeping marijuana in Schedule I. Meanwhile, DEA's own final brief asked the judge to expeditiously recommend moving marijuana to Schedule III. In Virginia, the Cannabis Control Authority released its first draft of adult-use regulations ahead of a planned July 1, 2027 launch, with a dual-use pathway that could give existing medical operators like Jushi Holdings (CSE: JUSH) (OTCQX: JUSHF), Green Thumb Industries (CSE: GTII) (OTCQX: GTBIF), Verano (Cboe CA: VRNO) (OTCQX: VRNOF), and Arboretum Virginia a real head start over new entrants.On the business side, Curaleaf (TSX: CURA) (OTCQX: CURLF) released a fourteen-point rebuttal against Aurora Cannabis (TSX: ACB) (NASDAQ: ACB), continuing to push its $4-per-share offer as Aurora keeps urging shareholders to reject it. Grown Rogue (CSE: GRIN) (OTC: GRUSF) officially began cultivation in Minnesota, Canopy Growth (NASDAQ: CGC) (TSX: WEED) expanded its Australian medical portfolio, and Vext Science (CSE: VEXT) (OTCQB: VEXTF) voluntarily closed an Ohio dispensary amid a health event investigation. In psychedelics, Compass Pathways (NASDAQ: CMPS) released strong 52-week Phase 3 data for COMP360 in treatment-resistant depression, and it was strong. Like, subscribe, and leave your comments!Want to stay updated on Cannabis, Small Cap, AI, and Crypto?Subscribe to our Daily Baked newsletter:https://newsletter.thedalesreport.com...Find us on social media and podcast platforms:✅ Facebook:   / thedalesreport  ✅ Twitter:   / thedalesreport  ✅ Instagram:   / dalesreport  ✅ LinkedIn:   / the-dales-report  Apple Podcasts: https://tinyurl.com/TDRTradetoBlackon...Spotify: https://tinyurl.com/TDRTradeToBlackon...Website: https://thedalesreport.com/For copyright matters, contact:[email protected] Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions made based on the information discussed.Full Disclosures: https://thedalesreport.com/website-te...

States have generated more than $15.8 billion in cannabis tax revenue over the past five years, and according to a newly updated federal report, the numbers are still growing. In this episode of TDR Cannabis in 5, host Shadd Dales breaks down reporting from Marijuana Moment on new U.S. Census Bureau data tracking cannabis excise tax revenue since Q3 2021.In just the most recent 12-month period, states and D.C. collected an estimated $3.55 billion in combined cannabis tax revenue, this despite marijuana still remaining federally illegal, still facing banking limitations, and still dealing with punitive taxation under 280E. In Q2 2026 alone, states brought in nearly $988 million, led by California at $161 million, Washington State at $153 million, and Michigan at over $110 million. Going back to when the Census Bureau started tracking in 2021, California has generated more than $3.3 billion total, with Washington State close behind at $2.3 billion.The episode also covers why national totals dipped in fiscal 2023, tied specifically to California eliminating its cultivation tax to compete with the illicit market, and how newer markets like Minnesota and Delaware are just starting to contribute. On a per-capita basis, Washington and Montana lead the country at more than $50 per resident annually, driven by excise rates of 37% and 20% respectively. With a separate Yale analysis estimating federal legalization alone could generate nearly $58 billion in new tax revenue over a decade, the gap between federal prohibition and state-level economic reality keeps getting harder to ignore.Want to stay updated on Cannabis, Small Cap, AI, and Crypto?Subscribe to our Daily Baked newsletter:https://newsletter.thedalesreport.com...Find us on social media and podcast platforms:✅ Facebook:   / thedalesreport  ✅ Twitter:   / thedalesreport  ✅ Instagram:   / dalesreport  ✅ LinkedIn:   / the-dales-report  Apple Podcasts: https://tinyurl.com/TDRTradetoBlackon...Spotify: https://tinyurl.com/TDRTradeToBlackon...Website: https://thedalesreport.com/For copyright matters, contact:[email protected] Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions made based on the information discussed.Full Disclosures: https://thedalesreport.com/website-te...

The debate over hemp-derived THC products is heating up again in Washington, and one businessman who operates on both sides of the cannabis industry says Congress needs to regulate the market, not destroy it. In this episode of TDR Cannabis in 5, host Shadd Dales breaks down an op-ed from Dylan Raap, founder and CEO of Vermont-based Upstate Elevator Supply Company, published through Marijuana Moment.Raap runs both a hemp company producing CBD and hemp-derived THC beverages, and a separate state-licensed adult-use cannabis business in Vermont, giving him a genuinely rare view across both industries. He doesn't oppose the synthetic cannabinoid ban still hitting November 12, but he strongly disagrees with the broader 0.4 milligram total THC per container standard set to take effect December 11, arguing that measuring THC per container instead of per serving could wipe out products never designed to intoxicate anyone in the first place, like full-spectrum CBD bottles containing trace amounts spread across 30 servings.Raap isn't defending the entire hemp market either, he acknowledges the 2018 Farm Bill created real unintended consequences, and argues that any genuinely intoxicating product should face real regulation, age restrictions, potency limits, clear labeling, independent testing, and packaging that can't be confused with anything marketed to kids. The episode covers where Congress actually stands right now, competing proposals from Andy Barr and Angie Craig, and Beth Van Duyne and Greg Landsman, and why the clock is becoming the biggest obstacle, businesses need far more than a few months to make manufacturing and distribution decisions before December 11 arrives.#TDRCannabisIn5 #HempIndustry #Delta8 #HempRegulation #DylanRaap #CannabisPolicy #CannabisNews #HempBan #FederalHempPolicy #CBDIndustryWant to see more Cannabis Reform?🎬    • Tyson Pushes Trump on Cannabis Reform | TD...  🎬    • Court Rejects Bid to Block Rescheduling | ...  🎬    • Is the New York Times Getting Cannabis Wro...  Want to stay updated on Cannabis, Small Cap, AI, and Crypto?Subscribe to our Daily Baked newsletter:https://newsletter.thedalesreport.com...Find us on social media and podcast platforms:✅ Facebook:   / thedalesreport  ✅ Twitter:   / thedalesreport  ✅ Instagram:   / dalesreport  ✅ LinkedIn:   / the-dales-report  Apple Podcasts: https://tinyurl.com/TDRTradetoBlackon...Spotify: https://tinyurl.com/TDRTradeToBlackon...Website: https://thedalesreport.com/For copyright matters, contact:[email protected] Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions made based on the information discussed.Full Disclosures: https://thedalesreport.com/website-te...

Mike Tyson is praising President Trump's decision to free two federal cannabis prisoners, but he's also making clear he hopes it's only the beginning. In this episode of TDR Cannabis in 5, host Shadd Dales breaks down reporting from Marijuana Moment on Trump's commutation of Jerry Haymon IV and Kevin Harden's sentences, and Tyson's direct involvement in getting them there.Tyson didn't just react after the fact, he personally wrote a letter to Trump advocating for both men's clemency, arguing no one should lose decades of their life for nonviolent cannabis offenses. Haymon had received a 10-year mandatory minimum for a marijuana distribution conspiracy and had already drawn bipartisan support, 36 members of Congress once urged President Biden to grant him clemency, though Biden's broader marijuana pardons stopped short of covering distribution sentences. Harden's case was even more dramatic, he was serving a full 30-year federal sentence before Trump's action ended it.The episode connects this to the bigger picture unfolding in Washington, Attorney General Todd Blanche's order moving state-licensed medical cannabis to Schedule III, and the broader DEA rescheduling process now sitting with an administrative law judge ahead of a final decision from Administrator Terrence Cole. Tyson has increasingly positioned himself as a vocal advocate on both fronts, rescheduling and clemency, and the bigger question now is whether Haymon and Harden are isolated cases, or the start of something bigger from the Trump administration.Want to stay updated on Cannabis, Small Cap, AI, and Crypto?Subscribe to our Daily Baked newsletter:https://newsletter.thedalesreport.com...Find us on social media and podcast platforms:✅ Facebook:   / thedalesreport  ✅ Twitter:   / thedalesreport  ✅ Instagram:   / dalesreport  ✅ LinkedIn:   / the-dales-report  Apple Podcasts: https://tinyurl.com/TDRTradetoBlackon...Spotify: https://tinyurl.com/TDRTradeToBlackon...Website: https://thedalesreport.com/For copyright matters, contact:[email protected] Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions made based on the information discussed.Full Disclosures: https://thedalesreport.com/website-te...

In our latest Trade to Black podcast, presented by Flowhub, hosts Shadd Dales and Anthony Varrell kick things off with the weekly Vantage Standard segment, presented by Vantage, joined by Chief Medical Officer Dr. Paul Shields. After previous episodes covering what changes are needed to fast-track the CBD Pilot Program, this week Dr. Shields lays out what a properly designed CBD Pilot Program actually looks like and what he'd recommend to regulators moving forward.In segment two, Adam Stettner, CEO of FundCanna, returns for his weekly appearance to cover a trio of stories. Croptober is here, and cannabis staffing firm Vangst expects to issue 10,000 W2s this harvest season alone, with growers needing anywhere from 10 to 200 extra workers and competition, and poaching, intensifying industry-wide. On the legal front, the U.S. Court of Appeals for the D.C. Circuit rejected an attempt by NDASA and MMJ International Holdings to freeze federal cannabis rescheduling while litigation continues, a real setback for opponents even as three consolidated lawsuits remain active. And a new U.S. Census Bureau report shows states have collected more than $15.8 billion in marijuana tax revenue since Q3 2021, including $3.55 billion in just the last year, with California, Washington State, and Michigan leading state totals.Want to stay updated on Cannabis, Small Cap, AI, and Crypto?Subscribe to our Daily Baked newsletter:https://newsletter.thedalesreport.com...Find us on social media and podcast platforms:✅ Facebook:   / thedalesreport  ✅ Twitter:   / thedalesreport  ✅ Instagram:   / dalesreport  ✅ LinkedIn:   / the-dales-report  Apple Podcasts: https://tinyurl.com/TDRTradetoBlackon...Spotify: https://tinyurl.com/TDRTradeToBlackon...Website: https://thedalesreport.com/For copyright matters, contact:[email protected] Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions made based on the information discussed.Full Disclosures: https://thedalesreport.com/website-te...

Opponents of cannabis rescheduling just suffered a real setback in federal court. In this episode of TDR Cannabis in 5, host Shadd Dales breaks down reporting from Marijuana Moment on a ruling from the U.S. Court of Appeals for the District of Columbia rejecting an attempt to immediately freeze the Trump administration's rescheduling process while broader legal challenges continue.The request came from the National Drug and Alcohol Screening Association and MMJ International Holdings, who argued rescheduling would cause irreparable harm and increase marijuana abuse by cutting taxes on cannabis companies. The court didn't buy it, ruling petitioners hadn't met the "stringent requirements" for a stay. That doesn't end the underlying lawsuits, three separate challenges, one from Smart Approaches to Marijuana and NDASA, another from a coalition including MMJ and anti-marijuana activists, and a third from the attorneys general of Indiana and Nebraska, remain consolidated before the court, with proposed briefing formats due within 30 days. The court also denied a separate motion from medical marijuana companies trying to formally intervene on the government's side, though they can still file amicus briefs.Meanwhile, the DEA's own administrative process keeps moving forward too, with the agency's final brief arguing marijuana no longer meets Schedule I criteria, citing over 30,000 practitioners treating six million patients across 43 jurisdictions, and asking the administrative law judge to move quickly on a Schedule III recommendation. Between the court ruling and the DEA's own position, the pressure against rescheduling just lost real ground on two fronts at once.Find us on social media and podcast platforms:✅ Facebook:   / thedalesreport  ✅ Twitter:   / thedalesreport  ✅ Instagram:   / dalesreport  ✅ LinkedIn:   / the-dales-report  Apple Podcasts: https://tinyurl.com/TDRTradetoBlackon...Spotify: https://tinyurl.com/TDRTradeToBlackon...Website: https://thedalesreport.com/For copyright matters, contact:[email protected] Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions made based on the information discussed.Full Disclosures: https://thedalesreport.com/website-te...

Three guests, three big topics on this episode of TDR Trade to Black, presented by Flowhub. Hosts Shadd Dales and Anthony Varrell kick things off with Flowhub CEO Kyle Sherman, breaking down what Labor Day 2026 sales data actually tells us about the cannabis industry. Across the Flowhub network, sales were only about 5% higher than a typical weekend, with no single breakout day and cart sizes staying flat — a sign the lift came from existing customers shopping a little more, not new demand. Kyle compares that against 4/20 2026, when dispensaries saw roughly 3.3x the revenue of an average Monday, and unpacks why retailers shouldn't treat every holiday like it deserves the same deep discounts heading into Green Wednesday, Thanksgiving, and Black Friday.Then longtime viewer and frequent commenter Brian Dombrowski, a 20+ year hemp and cannabis industry veteran, finally joins us on camera. Dombrowski lays out what real hemp regulation should look like with the December 11 federal deadline closing in, then gets into Texas, where he was directly involved in the industry pushback against the state's THC ban and what could come next for the state's midterms.We close out with Vantage Chief Medical Officer Dr. Paul Shields for our weekly Vantage Standard segment, breaking down the latest medical and regulatory news in the hemp and cannabinoid space.Subscribe and drop your thoughts in the comments below.#HempIndustry #CannabisNews #HempBan #TexasCannabis #HempRegulation #CannabisPolicy #THC #CBD #CannabisIndustry #TradeToBlackWant to see more Cannabis Reform?🎬    • Is the New York Times Getting Cannabis Wro...  🎬    • Democrat Calls for Full Cannabis Legalizat...  🎬    • Trump Grants Clemency to Two Cannabis Offe...  Want to stay updated on Cannabis, Small Cap, AI, and Crypto?Subscribe to our Daily Baked newsletter:https://newsletter.thedalesreport.com...Find us on social media and podcast platforms:✅ Facebook:   / thedalesreport  ✅ Twitter:   / thedalesreport  ✅ Instagram:   / dalesreport  ✅ LinkedIn:   / the-dales-report  Apple Podcasts: https://tinyurl.com/TDRTradetoBlackon...Spotify: https://tinyurl.com/TDRTradeToBlackon...Website: https://thedalesreport.com/For copyright matters, contact:[email protected] Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions made based on the information discussed.Full Disclosures: https://thedalesreport.com/website-te...

NORML is pushing back hard against the New York Times, accusing one of the country's most influential newspapers of presenting a one-sided picture of cannabis in America. In this episode of TDR Cannabis in 5, host Shadd Dales breaks down an op-ed from NORML Deputy Director Paul Armentano, published through Cultivated, challenging recent Times coverage on rising THC potency and cannabis use disorder.Armentano doesn't deny potency has increased, but points out concerns about stronger cannabis go back to Times reporting from 1978, and that consumers naturally titrate, adjusting how much they consume based on strength. On cannabis use disorder, SAMHSA data shows roughly 19.3 million Americans met the criteria in 2025, up from 16.7 million in 2021, but Armentano argues the diagnostic criteria itself, things like tolerance and withdrawal, can capture regular medical patients the same way it would capture someone with a genuine problem, without the same nuance applied to prescribed substances like opioids.The episode also covers the teen use question, where despite mixed state-level research, national data from Monitoring the Future shows past-year marijuana use among 12th graders sitting at just 26%, the lowest level recorded in roughly three decades. Armentano's broader argument isn't that cannabis is harmless, it's about proportionality, and whether media coverage applies the same scrutiny to cannabis that it does to alcohol and other legal substances. As federal cannabis policy edges closer to real change, how major outlets frame these stories increasingly shapes the public debate.#TDRCannabisIn5 #NORML #NewYorkTimes #CannabisPolicy #PaulArmentano #CannabisUseDisorder #THCPotency #CannabisNews #CannabisReform #MediaBiasWant to see more Cannabis Reform?🎬    • Democrat Calls for Full Cannabis Legalizat...  🎬    • Trump Grants Clemency to Two Cannabis Offe...  🎬    • McConnell vs. Paul: Hemp’s Kentucky Divide...  🎬    • Trump Signs Bill Delaying Hemp THC Ban | T...  Want to stay updated on Cannabis, Small Cap, AI, and Crypto?Subscribe to our Daily Baked newsletter:https://newsletter.thedalesreport.com...Find us on social media and podcast platforms:✅ Facebook:   / thedalesreport  ✅ Twitter:   / thedalesreport  ✅ Instagram:   / dalesreport  ✅ LinkedIn:   / the-dales-report  Apple Podcasts: https://tinyurl.com/TDRTradetoBlackon...Spotify: https://tinyurl.com/TDRTradeToBlackon...Website: https://thedalesreport.com/For copyright matters, contact:[email protected] Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions made based on the information discussed.Full Disclosures: https://thedalesreport.com/website-te...